Glassman Wealth Services Amphastar Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$27.93 - $31.27 $139 - $156	-5 Reduced 5.15%	92 $2,000
Q3 2022 Nov 09, 2022	SELL	$27.56 - $37.75 $275 - $377	-10 Reduced 9.35%	97 $3,000
Q2 2022 Aug 04, 2022	BUY	$29.79 - $42.29 $268 - $380	9 Added 9.18%	107 $4,000
Q1 2022 Aug 23, 2022	BUY	$22.96 - $36.45 $206 - $328	9 Added 10.11%	98 $4,000
Q4 2021 Feb 14, 2022	BUY	$18.14 - $23.29 $580 - $745	32 Added 56.14%	89 $2,000
Q3 2021 Nov 10, 2021	BUY	$17.83 - $21.49 $802 - $967	45 Added 375.0%	57 $1,000
Q2 2021 Aug 04, 2021	BUY	$17.11 - $20.92 $205 - $251	12 New	12 $0
Q1 2020 May 12, 2020	SELL	$12.66 - $20.08 $177 - $281	-14 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$17.07 - $20.64 $614 - $743	-36 Reduced 72.0%	14 $0
Q3 2019 Nov 01, 2019	BUY	$19.12 - $22.62 $726 - $859	38 Added 316.67%	50 $1,000
Q2 2019 Aug 08, 2019	BUY	$18.92 - $22.96 $227 - $275	12 New	12 $0

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.